GTCM
TMCI icon

Gyon Technologies Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Gyon Technologies Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,000
Closed -$205K – 559
2021
Q4 		$205K Buy
+11,000
New +$227K 0.04% 512

Other funds holding TMCI

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Gyon Technologies Capital Management's TMCI Position: Q1 2022 in Review

Gyon Technologies Capital Management sold out of Treace Medical Concepts (TMCI) in Q1 2022, closing a stake of 11,000 shares — an estimated $205K sold.

Gyon Technologies Capital Management first reported a position in TMCI in Q4 2021 and held it in 1 quarter. The position peaked at $205K in Q4 2021. 75 funds tracked by Wall St. Rank hold TMCI as of Q1 2022.

  • Gyon Technologies Capital Management reported no remaining Treace Medical Concepts position as of Q1 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 11,000 Treace Medical Concepts shares in Q1 2022, an estimated $205K.
  • Gyon Technologies Capital Management first reported a position in Treace Medical Concepts in Q4 2021 and held it in 1 quarter.
  • Gyon Technologies Capital Management's Treace Medical Concepts position peaked at $205K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2022, filed 12 May 2022.